Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 1
1981 1
1982 1
1983 1
1984 2
1988 1
1989 3
1991 1
1992 1
1993 3
1994 3
1995 5
1996 2
1997 2
1999 2
2001 1
2002 3
2003 3
2004 3
2005 10
2006 6
2007 5
2008 3
2009 6
2010 3
2011 2
2012 5
2013 2
2014 1
2015 8
2016 8
2017 8
2018 9
2019 6
2020 5
2021 8
2022 5
2023 7
2024 15
2025 12
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major EGFR Mutations.
Takamori S, Endo M, Hamada A, Ohara S, Fukuda S, Tomioka Y, Takamori S, Osoegawa A, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Kinoshita F, Hayasaka K, Notsuda H, Nagano T, Matsudo K, Hashinokuchi A, Matsubara T, Katsumata S, Shiono S, Soh J, Ohde Y, Shimokawa M. Takamori S, et al. Among authors: katsumata s. Clin Lung Cancer. 2025 May;26(3):e172-e180.e5. doi: 10.1016/j.cllc.2024.12.011. Epub 2024 Dec 26. Clin Lung Cancer. 2025. PMID: 39824660
Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation - A real-world database study in Japan: The CReGYT-01 EGFR study.
Katsumata S, Shimokawa M, Hamada A, Haratake N, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Kinoshita F, Hayasaka K, Notsuda H, Takamori S, Muto S, Takanashi Y, Mizuno K, Kawase A, Hayakawa T, Sekihara K, Toda M, Matsuo S, Takegahara K, Hashimoto M, Nakahashi K, Endo M, Ozawa H, Fujikawa R, Tomioka Y, Namba K, Matsubara T, Suzuki J, Watanabe H, Takada K, Hoshino H, Kaiho T, Toyoda T, Kouki Y, Shiono S, Soh J, Ohde Y. Katsumata S, et al. Eur J Cancer. 2024 Apr;201:113951. doi: 10.1016/j.ejca.2024.113951. Epub 2024 Feb 22. Eur J Cancer. 2024. PMID: 38417299
Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus).
Nomura K, Watanabe T, Takamori S, Hamada A, Suda K, Ito M, Ohara S, Oiki H, Fukami T, Muto S, Katsumata S, Konno H, Hayasaka K, Toyoda T, Endo M, Takamori S, Nakatsuka M, Tenpaku H, Takegahara K, Matsubara T, Kinoshita F, Akamine T, Nakamura R, Mizuno K, Nakagawa K, Kaneda S, Okada S, Kosai K, Notsuda H, Sakane T, Shinohara S, Abe M, Haratake N, Tane S, Hanawa R, Tarukawa T, Namba K, Toda M, Kawaguchi T, Takada K, Minegishi K, Kurihara N, Iguchi T, Aokage K, Tsutani Y, Tsuboi M, Soh J, Shimokawa M, Ohde Y. Nomura K, et al. Among authors: katsumata s. Ann Thorac Surg. 2025 Oct 30:S0003-4975(25)01059-8. doi: 10.1016/j.athoracsur.2025.09.054. Online ahead of print. Ann Thorac Surg. 2025. PMID: 41173344
Similar Trend in Benefit of Adjuvant Platinum in Lung Cancer Patients Irrespective of Epidermal Growth Factor Receptor Mutation Status.
Suda K, Fujino K, Yoshikawa M, Shien K, Suzawa K, Nomura K, Fukuda S, Ohara S, Hamada A, Kinoshita F, Hayasaka K, Notsuda H, Takamori S, Muto S, Katsumata S, Shimokawa M, Soh J, Tsutani Y; CReGYT-EGFR Study Group. Suda K, et al. Among authors: katsumata s. Eur J Cardiothorac Surg. 2025 Jul 1;67(7):ezaf239. doi: 10.1093/ejcts/ezaf239. Eur J Cardiothorac Surg. 2025. PMID: 40690369
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study).
Nomura K, Takada K, Kinoshita F, Muto S, Matsubara T, Kouki Y, Katsumata S, Hamada A, Haratake N, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Suzuki H, Okamoto T, Hirai F, Aokage K, Shiono S, Soh J, Tsuboi M, Shimokawa M, Ohde Y. Nomura K, et al. Among authors: katsumata s. Int J Cancer. 2025 Apr 1;156(7):1480-1491. doi: 10.1002/ijc.35270. Epub 2024 Nov 21. Int J Cancer. 2025. PMID: 39569608
Impact of TP53 Co-Mutation on Clinicopathological Features, Prognosis, Recurrence Patterns, and the Efficacy of EGFR-TKI Treatment After Recurrence in Resected Early-Stage EGFR-Mutated Lung Adenocarcinoma.
Masuda T, Katsumata S, Isaka M, Serizawa M, Kawata T, Asami M, Yamaguchi D, Matsushima K, Hayasaka K, Kojima H, Yokomakura N, Konno H, Nagashima T, Urakami K, Yamaguchi K, Ohde Y. Masuda T, et al. Among authors: katsumata s. Clin Lung Cancer. 2025 Sep;26(6):e374-e381. doi: 10.1016/j.cllc.2025.04.009. Epub 2025 Apr 25. Clin Lung Cancer. 2025. PMID: 40410020
Preoperative Immune-Related Adverse Events in Resectable NSCLC Treated With Neoadjuvant Nivolumab Plus Chemotherapy: A Multicenter Retrospective Analysis.
Watanabe T, Nomura K, Takamori S, Tane S, Ohara S, Oiki H, Katsumata S, Endo M, Takamori S, Nakatsuka M, Tenpaku H, Nakamura R, Notsuda H, Namba K, Minegishi K, Tanahashi M, Tsuboi M, Soh J, Shimokawa M, Ohde Y. Watanabe T, et al. Among authors: katsumata s. JTO Clin Res Rep. 2025 Oct 30;7(1):100930. doi: 10.1016/j.jtocrr.2025.100930. eCollection 2026 Jan. JTO Clin Res Rep. 2025. PMID: 41496777 Free PMC article.
Adjuvant therapy in pStage IA1-IIA lung adenocarcinoma (pN0): A multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study).
Fujino K, Suda K, Yoshikawa M, Shien K, Suzawa K, Nomura K, Kinoshita F, Takamori S, Hayasaka K, Notsuda H, Muto S, Katsumata S, Shimokawa M, Soh J, Ohde Y, Matsushima R, Shinchi Y, Motooka Y, Saishoji H, Koga T, Ikeda K, Suzuki M. Fujino K, et al. Among authors: katsumata s. Lung Cancer. 2025 Aug;206:108672. doi: 10.1016/j.lungcan.2025.108672. Epub 2025 Jul 17. Lung Cancer. 2025. PMID: 40706272 Free article.
167 results